With 20+ years experience in accounting and 12+ years experience in web development, I spend half of my time as a finance officer and bookkeeper. The other half of my time is spent coding, deploying, consulting and maintaining a variety of management web applications.

Todd Ruthman graduated from the University of Waterloo in 1992 with a BASc in Systems Design Engineering. This educational background instilled in him a fascination for understanding the integrated interactions among people, nature, and technology. For nearly two decades, he has been applying this multidisciplinary perspective in the development of science-based and risk-based solutions for clients. His team specializes in creating IT solutions that support risk-informed decision-making, utilizing either custom web applications or off-the-shelf software such as Excel, Analytica, and R.

Now serving as RSI's Vice-President Communications and Strategic Initiatives, for years Cemil has provided organizations with guidance designed to transmit mission-critical messages. An anti-tobacco campaign is not about promoting a strategy, it's about saving...

Dr. Peter Aggett, a Pediatrician specializing in Gastroenterology, Metabolism, and Chemical Pathology, focuses on essential trace elements in health and disease. He holds the position of Emeritus Head at Lancashire School of Health and Postgraduate Medicine and is a Professor of Child Health and Nutrition at the University of Central Lancashire. His extensive career includes roles in public health nutrition, nutrient risk assessment, and food safety, contributing to scientific advisory committees worldwide. Following retirement, Dr. Aggett continued as an External Expert for EFSA, reviewing Dietary Reference Values for essential micronutrients.

Dr. Calvin Willhite is a renowned expert in developmental toxicology and quantitative structure-activity relationships, with a substantial publication record. He has played key roles in influential organizations and committees, including the National Academy's Committee on Toxicology, the U.S. EPA's National Advisory Committee, and the IARC Cancer Chemoprevention Panel. Dr. Willhite is a member of the Society of Toxicology and is featured in notable biographical publications. Currently, he serves as an Associate Expert with Risk Sciences International, contributing to health risk assessments for various chemicals, both man-made and naturally-occurring.

Natalia Shilnikova earned her medical degree and a PhD in Medical Sciences, focusing on epidemiology related to nuclear facilities. She moved to Canada in 2007, joining the University of Ottawa McLaughlin Centre for Population Health Risk Assessment. Since joining Risk Sciences International in 2011, Dr. Shilnikova has worked on projects involving toxicology, epidemiology, and human health risk assessment, including systematic reviews and toxicity profiles for various chemicals and drugs. She has also contributed to post-approval surveillance of novel cancer drugs.

Emma Hartnett is an internationally recognized expert in risk assessment, specializing in toxicological, microbiological, and nutritional hazards. She holds a B.Sc. in Microbiology and a Ph.D. in Statistics and Modelling Science, where her thesis work focused on quantitative risk assessment for campylobacter infection from chicken. Hartnett has developed a variety of decision support tools addressing issues from infectious diseases to bioterrorism preparedness. She frequently contributes to WHO and FAO initiatives, and has been selected for the Joint FAO/WHO Expert Meetings on Microbiological Risk Assessment Roster of Experts for 2018-2022.

Greg Paoli earned both his Bachelor's and Master's degrees from the University of Waterloo, specializing in engineering and systems design. His early career involved diverse research projects at the University of Waterloo's Institute for Risk Research. Greg later founded Decisionalysis Risk Consultants in 1997 and co-founded Risk Sciences International in 2006. He has served on multiple high-profile committees, including those under the U.S. National Academy of Sciences. As CEO of Risk Sciences International, Greg focuses on risk-based regulatory transformations and has developed enabling technologies like FDA-iRISK. His work spans various sectors, from food and chemical safety to public health, and he continues to contribute to the advancement of risk-based decision-making methodologies.